Australia Cracks Down on Illegal Sales of E-Cigarettes

Oct.27.2022
Australia Cracks Down on Illegal Sales of E-Cigarettes
Amid increasing numbers of high school students using e-cigarettes, Australian retailers selling vaping products without a doctor's prescription are breaking the law.

Since October, it has been illegal for retailers in Australia to sell e-cigarette products without a doctor's prescription. State law enforcement officers have been conducting spot checks on convenience stores, gas stations, and tobacco shops, recruiting undercover teenagers to attempt to purchase these products.


Vicky Sheppard from the public health department of the southeastern Sydney local health district in New South Wales has announced that a recent inspection was conducted due to the increasing number of high school students using e-cigarettes. She stated that this figure has significantly increased in 2021. "We are currently in discussions with principals who are very aware and concerned about the growing number of young people using e-cigarettes. Unfortunately, we have received reports of e-cigarette use not only among young students but also among primary school students," Sheppard added.


Similarly, the New South Wales Minister for Education, Sarah Mitchell, has announced a series of actions to address issues within schools. "This is an issue. I mean, obviously we're seeing more e-cigarettes amongst young people; e-cigarettes in schools are increasingly coming to our attention," she said. "Schools are smoke-free environments, and tobacco products, including e-cigarettes, are prohibited from being used on school grounds.


Mitchell added that the Department of Education is currently in discussions with the New South Wales Department of Health to find a holistic approach to addressing the issue. "I do believe that a whole of government - and in fact, whole of community approach - is needed to educate our children about the dangers of vaping and the potential legal impacts," he said. Therefore, an anti-vaping movement is being initiated.


At the same time, Mendelson revealed some inaccurate statements made by the New South Wales campaign team and provided a detailed explanation of each one.


Recently, a public health expert mentioned the regulations in New Zealand where retailers can responsibly sell nicotine products over the counter. However, anyone violating the strict regulations in Australia will face hefty fines and in some cases, even imprisonment.


According to Mendelsohn, while regulations in New Zealand are not perfect, they are a good starting point and Australia should follow suit. "New Zealand's regulations make Australia look bad. They are evidence-based rather than political and ideological. They are a model for good public health policy on e-cigarettes that will save lives.


The requirement for a prescription for nicotine in Australia is complex, expensive and unnecessary, which makes it harder to access e-cigarette products than traditional cigarettes. Is this really what Greg Hunt wants?" he concluded.


Statement:


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truthfulness or accuracy of its contents. The translation of this article is only intended for industry communication and research purposes.


Due to limitations in our translation ability, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any statements or positions related to domestic issues, Hong Kong, Macao, Taiwan, and foreign affairs.


The copyright of compiled information belongs to the original media and author, and please contact us to delete if there is any infringement.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts held a U.S. compliance briefing in Shenzhen to help vaping, heated tobacco and nicotine pouch supply chain companies strengthen PMTA support capabilities. The event focused on supplier documentation, quality systems, traceability, TPMF/TPMP pathways, age verification and customer audit readiness as U.S. compliance expectations increasingly extend deeper into the nicotine supply chain.
Events
Jun.12
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Haypp Report Shows Nicotine Pouches Gaining Ground as a Vape Alternative in the UK
Haypp Report Shows Nicotine Pouches Gaining Ground as a Vape Alternative in the UK
According to Haypp’s 2026 UK Nicotine Report, nicotine pouches are increasingly replacing both cigarettes and vaping. The UK market grew sharply, with Haypp and Northerner reporting a 60% year‑on‑year sales increase in 2025. Notably, 40% of users adopted pouches to quit vaping, nearly matching the 43% who used them to stop smoking. This indicates pouches are expanding beyond traditional smoking cessation and gaining traction among adults seeking non‑inhalable nicotine alternatives.
Jul.01
BAT Uzbekistan and Regulators Discuss Production Modernization and Export Expansion
BAT Uzbekistan and Regulators Discuss Production Modernization and Export Expansion
A meeting was held at the Department for Combating Economic Crimes under the General Prosecutor’s Office of Uzbekistan with representatives of British American Tobacco Uzbekistan. Participants included the department’s leadership, the Inspectorate for Regulation of the Alcohol and Tobacco Market, and business representatives.
May.09 by 2FIRSTS.ai
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland’s Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026 has passed final stage in the Dáil and will move to the Seanad, with measures to limit vape flavours to tobacco or unflavoured products and tighten rules on packaging colours, retail advertising, in-store displays and sales of nicotine pouches to minors.
News
Jun.26 by 2Firsts Perspectives
BAT Restructuring to Affect 9,000 Roles as Tobacco Group Pushes Cost Cuts and AI
BAT Restructuring to Affect 9,000 Roles as Tobacco Group Pushes Cost Cuts and AI
British American Tobacco (BAT) plans to cut about 5,500 jobs globally and shift around 3,500 roles to strategic partners by the end of 2026, affecting about 9,000 roles in total, as the company seeks to simplify operations, strengthen technology capabilities and deliver £600 million in annual savings by 2028.
BAT
Jun.29